Jump to content

Most advanced disease share clinically actionable AR mutation


Recommended Posts

Hi Guys,

Here’s a link relating to advanced prostate cancer research, showing for the first time that in up to 90 percent of cases there is a clinically actionable mutation of the androgen receptor (the protein on the outside of the prostate cancer cells that testosterone locks onto, providing both fuel for the cell and a signal for the cell to reproduce).    


There’s plenty of reason for optimism!

Alan B

Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...